Galapagos (GLPG) News Today $32.03 +0.16 (+0.50%) Closing price 10/23/2025 04:00 PM EasternExtended Trading$32.66 +0.63 (+1.98%) As of 10/23/2025 04:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GLPG Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Galapagos Unveils Promising Data for TYK2 Inhibitor GLPG3667October 23 at 9:51 PM | tipranks.comGalapagos to Present In Vitro Data at ACR Convergence 2025 Suggesting Differentiation of GLPG3667 from Other TYK2 InhibitorsOctober 23 at 4:01 PM | globenewswire.comRBC Capital Maintains Galapagos NV - Depositary Receipt (GLPG) Sector Perform RecommendationOctober 23 at 6:02 AM | msn.comGalapagos price target raised to $28 from $27 at RBC CapitalOctober 22 at 7:47 PM | msn.comGalapagos falls after plans to shut down cell therapy unitOctober 21 at 8:40 AM | msn.comGalapagos NV to Wind Down Cell Therapy Business Following Strategic ReviewOctober 21 at 6:31 AM | tipranks.comBiotech firm Galapagos to wind down cell therapy businessOctober 21 at 3:39 AM | reuters.comGalapagos Announces Intention to Wind Down Cell Therapy Business as Part of the Company’s Ongoing TransformationOctober 21 at 3:39 AM | markets.businessinsider.comGalapagos Announces Intention to Wind Down Cell Therapy Business as Part of the Company's Ongoing TransformationOctober 21 at 2:30 AM | globenewswire.comBrokerages Set Galapagos NV (NASDAQ:GLPG) Price Target at $26.00October 20, 2025 | americanbankingnews.comGalapagos Appoints Fred Blakeslee as General CounselOctober 16, 2025 | tipranks.comGalapagos Announces Appointment of Fred Blakeslee as General CounselOctober 16, 2025 | finance.yahoo.comKepler Capital Remains a Sell on Galapagos (0JXZ)October 11, 2025 | theglobeandmail.comBiotechnology firm Galapagos receives offers for cell therapy businessOctober 3, 2025 | msn.comBiotechnology firm Galapagos receives offers for cell therapy businessOctober 3, 2025 | msn.comGalapagos provides update on strategic alternatives for cell therapy businessOctober 1, 2025 | msn.comGalapagos Updates on Cell Therapy Business Strategic ReviewOctober 1, 2025 | tipranks.comBiotechnology firm Galapagos receives offers for cell-therapy businessOctober 1, 2025 | reuters.comGalapagos Provides Update on Strategic Alternatives for Its Cell Therapy BusinessOctober 1, 2025 | globenewswire.comGalapagos (NASDAQ:GLPG) Sets New 12-Month High - What's Next?September 30, 2025 | marketbeat.comGalapagos (AMS:GLPG) Is In A Good Position To Deliver On Growth PlansSeptember 29, 2025 | finance.yahoo.comStocks To Watch: Galapagos ADR Sees RS Rating Rise To 82September 22, 2025 | msn.comGalapagos NV (GLPG)’ CAR-T Therapy Hits 97% Response Rate in Lymphoma TrialSeptember 12, 2025 | finance.yahoo.comGalapagos NV (GLPG)’ CAR-T Therapy Hits 97% Response Rate in Lymphoma TrialSeptember 12, 2025 | msn.com11 Best Performing Biotech Stocks So Far in 2025September 10, 2025 | insidermonkey.comGalapagos ADR Reaches 80-Plus Relative Strength Rating BenchmarkSeptember 9, 2025 | msn.comGalapagos NV Advances in CAR T Cell Therapy for Non-Hodgkin LymphomaSeptember 7, 2025 | msn.comBVF Inc. IL Sells 115,000 Shares of Galapagos NV $GLPGSeptember 5, 2025 | marketbeat.comOLD Mission Capital LLC Invests $1.89 Million in Galapagos NV $GLPGSeptember 2, 2025 | marketbeat.comGalapagos NV Launches New Subscription Right Plan for ManagementAugust 7, 2025 | tipranks.comGalapagos Creates New Subscription Right PlanAugust 7, 2025 | globenewswire.comGalapagos shares drop 6% as Deutsche Bank cuts rating on strategy concernsAugust 7, 2025 | investing.comGalapagos NV Secures FDA RMAT Designation for GLPG5101August 6, 2025 | tipranks.comGalapagos NV Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to GLPG5101 for the Treatment of Relapsed/Refractory Mantle Cell LymphomaAugust 6, 2025 | globenewswire.comDeutsche Bank downgrades Galapagos to Sell amid ‘too much uncertainty’August 6, 2025 | msn.comGalapagos Appoints New Directors to Strengthen BoardJuly 23, 2025 | tipranks.comGalapagos Bolster Leadership Team with Seasoned Life Sciences Executives to Accelerate Business TransformationJuly 23, 2025 | globenewswire.comGalapagos Welcomes Seasoned Pharmaceutical Executives Dawn Svoronos and Jane Griffiths to Its Board of DirectorsJuly 23, 2025 | globenewswire.comGalapagos Reports Half-Year 2025 Financial Results and Provides Second Quarter Business UpdateJuly 23, 2025 | globenewswire.comGalapagos NV ADR News (GLPG) - Investing.comJuly 9, 2025 | investing.comGalapagos N.V. ADR Advanced Charts | GLPG | Barron'sJune 29, 2025 | barrons.comGalapagos NV ADR Analysis & Opinion (GLPG) - Investing.comJune 28, 2025 | investing.comNotable Two Hundred Day Moving Average Cross - GLPGJune 25, 2025 | nasdaq.comGalapagos NV: Galapagos Appoints Aaron Cox as Chief Financial OfficerJune 23, 2025 | finanznachrichten.deGalapagos Appoints Aaron Cox as Chief Financial OfficerJune 23, 2025 | globenewswire.comGalapagos Unveils Promising Results for GLPG5101 at ICML 2025June 20, 2025 | tipranks.comGalapagos Presented New Data at ICML 2025 From Cohort 3 of ATALANTA-1 in Relapsed/Refractory Indolent NHL Patients, Demonstrating High Complete Response and MRD Negativity Rates With CAR-T Candidate GLPG5101June 18, 2025 | globenewswire.comOwning 37% shares,institutional owners seem interested in Galapagos NV (AMS:GLPG),June 17, 2025 | uk.finance.yahoo.comGalapagos to Present New ATALANTA-1 CAR-T Data at EHA 2025, Highlighting Low Toxicity and Rapid, Decentralized Delivery of Fresh, Early-Memory-Enriched GLPG5101 in R/R NHLJune 12, 2025 | globenewswire.comGalapagos NV (NASDAQ:GLPG) Given Consensus Rating of "Reduce" by BrokeragesJune 12, 2025 | marketbeat.com Get Galapagos News Delivered to You Automatically Sign up to receive the latest news and ratings for GLPG and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GLPG Media Mentions By Week GLPG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GLPG News Sentiment▼0.370.57▲Average Medical News Sentiment GLPG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GLPG Articles This Week▼123▲GLPG Articles Average Week Get the Latest News and Ratings for GLPG and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Galapagos and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies AIMDW News Today BCTXW News Today CURX News Today GDTC News Today ENGNW News Today FBIOP News Today GOVXW News Today INDV News Today JSPRW News Today MNOV News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GLPG) was last updated on 10/24/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredApple's secret partnerThe Tiny Company Apple Can’t Live Without A tiny company holds the key to Apple’s biggest breakthrough sinc...The Oxford Club | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredMiss This IRS Strategy Now, Regret It LaterWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | SponsoredGold surges past $4,200 … but this has beat gold by 1,000xGold has surged past $4,200 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galapagos NV Please log in to your account or sign up in order to add this asset to your watchlist. Share Galapagos With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GLPG Stock Alerts